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Abstract
Neoadjuvant (preoperative) therapy and combined modality therapy have become focuses of interest in the effort to prolong survival and to
reduce recurrence rates in patients with esophageal cancer. Staging of the tumor is a critical step in establishing which therapeutic option is
appropriate. Once surgical management is advocated, adequate medical imaging is crucial in determining individual anatomical variations.
In this communication we report a case of a patient with azygos continuation who underwent chemoradiotherapy with successful
downstaging of tumor status from T3 – 4 to T0 and a nodal status from N1 to N0 as evaluated by medical imaging and who then proceeded to
curative surgical resection. This case highlights the potential ability of radiological techniques to confirm both anatomical variations and
responses to neoadjuvant therapy.
q 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Therapy for esophageal carcinoma is influenced by the
knowledge that in most of these patients, local tumor
invasion or distant metastatic disease precludes cure.
Appropriate selection of patients with esophageal carci-
noma for surgery or chemo-radiotherapy depends critically
on accurate staging. Multimodality therapy (chemotherapy
and radiation therapy) followed by total esophagectomy has
been reported to improve survival compared with esopha-
gectomy alone, with an approximate doubling of survival
[1]. In addition, in patients with locally advanced disease the
potential benefit of the preoperative chemoradiation
becomes more evident; many patients have the stage of
their disease lowered and become eligible for complete
resection.
In selected cases, some anatomical variations and
congenital malformations may adversely influence surgical
manipulation. Certain anatomical structures – that are
normally resected in order for establishing an R0-resection
– must be spared if an anomaly is suspected. With respect
to esophageal malignancies, this is the very case with
the azygos system. The azygos vein is normally resected
during esophagectomy. Ligation of the azygos vein,
however, in the presence of an azygos-caval anomaly
abolishes venous drainage from the lower half of the body,
leading to venous hypertension and ultimately to death.
Therefore, as we present that in this communication,
medical imaging is not only essential in staging of the
tumor, but also crucial in determining such anomalies prior
to surgical intervention.
2. Case report
A 52-year-old white male with a history of epilepsy
presented with dysphagia for semi-solids and weight loss of
10 kg during a 3-month period. He smoked three packs of
cigarettes daily and admitted to intermittently heavy alcohol
ingestion. His current medication was tiapride; he had no
family history of note. He had no other symptoms and
physical examination was unremarkable.
The plain chest radiograph was also completely normal.
Computed tomography (CT) of the chest and abdomen
revealed an advanced mid-esophageal mass with extensive
periaortic and aortic window lymphadenopathy. Scans
proved invasion of the trachea. The images also showed
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a dilated azygos vein and arch in their paravertebral course
associated with non-visualization of the intrathoracic
inferior vena cava (IVC) (Fig. 1). Sections through the
upper abdomen showed absence of supra-renal IVC with
dilated azygos vein. The cardiac chambers, lungs, liver, and
hepatic veins were normal, and there was no situs inversus.
Taken together, an azygos continuation of the IVC was
suspected. However, CT scans also revealed invasion of the
dilated anomalous azygos vein.
An upper gastrointestinal (GI) gastrografin contrast
radiograph series showed a mid-esophageal filling defect.
The patient had undergone esophago-gastro-duodenoscopy
(EGD), which revealed a mass at 27 cm from the incisors. A
biopsy from the lesion disclosed squamous cell carcinoma.
Bronchoscopy demonstrated signs of external compression
of the trachea with no mucosal lesion. By utilizing complex
medical imaging, the locally advanced tumor was staged as
T4N1M0 and was deemed unresectable by both oncological
and technical means.
The patient then underwent neoadjuvant chemora-
diotherapy, which he tolerated well without complication.
Chemotherapy consisted of two cycles of carboplatin and
5-fluorouracil, administered 3 weeks apart. Three-hundred
mg of carboplatin was infused on day 1 as a single dose. A
total of 1000 mg of 5-fluorouracil was given as a continuous
infusion on days 1–5. External beam radiation therapy was
concurrently administered during chemotherapy. The
patient received a total dose of 27.5 Gy in 2.5 Gy daily
fractions.
After neoadjuvant chemoradion, repeat CT scans of the
chest and abdomen demonstrated total reduction in the size
of the tumor and showed no evidence of metastatic disease
(Fig. 2). Both trachea and azygos vein were free of
neoplastic invasion. The smaller peritumoral and periaortic
nodes were no longer visible. CT scans have also re-
confirmed the presence of azygos continuation – a
congenital malformation that a general surgical team
scarcely encounters with. At repeat EGD no evidence of
his primary tumor could be found. Bronchoscopy revealed
neither endotracheal, nor endobronchial propagation of the
carcinoma. Taken together, the patient was successfully
down-staged.
He then proceeded to successful Ivor-Lewis esophagec-
tomy, sparing the azygos vein, with an uneventful post-
operative recovery. Pathology of the resected specimen
found residual primary tumor in the esophagus (histologi-
cally: non-keratinizing squamous cell carcinoma) and no
evidence of malignancy in any of the six lymph nodes
examined.
At follow-up 12 months later the patient was asympto-
matic with no evidence of recurrent disease clinically or
on CT.
3. Discussion
Esophageal cancer is notorious for its aggressive biologic
behavior; it infiltrates locally, involves adjacent lymph
nodes, and metastasizes widely by hematogenous spread.
Unfortunately, most patients still present with locally
advanced (stage T3 and/or N1) disease. Prognosis and
outcomes are determined by stage. Our responding patient
Fig. 1. The CT scan demonstrates a mid-esophageal mass with the invasion
of the trachea (arrow) and the presence of mediastinal lymphadenomegaly.
Images also prove dilated azygos vein and arch in their paravertebral course
(asterisk). In conjunction with an undetectable inferior vena cava, the
diagnosis of azygos continuation was made.
Fig. 2. Chest CT image proves a down-staged mid-esophageal mass after
neoadjuvant chemoradiotherapy (arrow). The tumor and lymphadenome-
galies are unappreciable. Dilated azygos vein and arch (asterisk) along with
an absent intrathoracic inferior vena cava reconfirm azygos-caval anomaly.
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with a locally advanced disease underwent preoperative
neoadjuvant chemoradiation. He was successfully down-
staged, and then proceeded to curative surgical resection. He
returned to good health and has returned to work. He
remains free of disease 12 months after the initiation of
therapy.
Preliminary evidence suggests that multimodality treat-
ment with radiation therapy plus chemotherapy followed by
resection is superior to any therapy alone. Chemoradiother-
apy is used preoperatively to treat micrometastases and to
reduce the size of the tumor to improve resectability rate.
Such a regimen should increase the R0 resection rate in
patients with locally advanced tumors and in patients with
tumors at unfavorable locations, should reduce the rate of
local and distant recurrences, and should thereby increase
the chances for long-term survival.
In performing esophagectomy, the azygos vein and the
thoracic duct are resected along with the primary specimen.
Developmental anomalies of the IVC are relatively rare,
occurring in ,1% of patients with congenital heart disease
[2]. When developmental interruption of the infrahepatic
IVC occurs, venous return from the lower body is via the
azygos or hemiazygos venous system. A high incidence of
associated congenital cardiac malformations, errors in
abdominal situs, asplenia, and polysplenia were sub-
sequently reported. This anomaly was first described by
Stark in the mid-19th century [3]. Ever since a couple of
cases have been published, however this is the first report in
which successful esophagectomy was performed in this rare
disorder. The anomaly was detected in the past by either
inferior vena cavography, transfemoral cardiac catheteriza-
tion, or exploratory thoracotomy. With the advent of CT
scan and magnetic resonance imaging (MRI), the normal
anatomy of the azygos vein and its abnormalities are well
visualized without the need for invasive procedures.
In the case of our patient with esophageal cancer
invading adjacent structures, the anomalous azygos vein
was not free of neoplastic involvement at presentation.
Because of the unfortunate association of his malignancy
with an azygos-caval anomaly, this simple finding had
furthered the locally advanced oncologically unresectable
mid-esophageal tumor to be deemed technically unmanage-
able by surgical means. Having undergone preoperative
chemoradiation, however, the patient became free of
invasion of the azygos system – the only vessel through
which veins from his lower half of the body drained.
Therefore in such cases, just as presented in this brief
clinical report, neoadjuvant therapy is ultimately essential
not only in down-staging a tumor, but making a neoplastic
lesion both oncologically and technically resectable.
Moreover, failure to detect the presence of azygos-caval
anomaly may be lethal for patients undergoing esophageal
or other thoracic surgery, as its ligation abolishes venous
drainage from the lower half of the body, resulting in venous
hypertension and death. Invasive procedures can be avoided
if the diagnosis is suspected and a CT scan or MRI
performed.
Versatile radiological techniques have emerged that are
essential in staging and re-staging the disease after
preoperative treatment, and verifying responses to neoadju-
vant therapy. Many-sided medical imaging is also impera-
tive in confirming anatomical variations. Taken together,
hand-in-hand collaboration of the surgical team with
oncological and radiological units is crucial in giving the
patient the best available treatment utilizing evidence-based
medicine.
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